The preliminary effects of henna on chemotherapy-induced peripheral neuropathy in women receiving oxaliplatin-based treatment: A parallel-group, randomized, controlled pilot trial

Basit Öğe Kaydı
dc.contributor.authorArslan, Selda
dc.contributor.authorBahceli, Pinar Zorba
dc.contributor.authorIlik, Yeter
dc.contributor.authorArtac, Mehmet
dc.date.accessioned2024-02-23T14:02:44Z
dc.date.available2024-02-23T14:02:44Z
dc.date.issued2020
dc.departmentNEÜen_US
dc.description.abstractPurpose: Chemotherapy-induced peripheral neuropathy (CIPN) may frequently occur in patients receiving oxaliplatin-based treatment. The aim of the present parallel-group, randomized, controlled pilot trial was to investigate the effect of henna on CIPN in women receiving oxaliplatin-based treatment. Method: Sixty female patients receiving oxaliplatin-based treatment were randomly divided into two groups, i.e., one intervention group (n = 30) where henna was applied topically and one control group (n = 30) that received routine treatment and care. Women in the intervention group were provided a pack of henna prepared by the investigators following each treatment course (2nd, 3rd, and 4th courses) and were instructed to apply the henna on their palms, fingers, and soles. The chemotherapy-induced peripheral neuropathy assessment tool (CIPNAT) was completed by women subsequent to the 2nd (baseline), 3rd, and 4th courses of treatment. Results: The intragroup assessment performed for the intervention group revealed that the total CIPNAT score significantly declined in the intervention group (p < 0.05). The score changes by time in the intervention and control groups were in favour of the intervention group, and the effect size for group x time interaction was eta(2) = 0.169. Similarly, regarding the symptoms intervention section of the tool, a positive change by time in the intervention group was observed, and the effect size concerning this change was large, i.e., eta(2) = 0.284. Conclusions: The present study results showed that henna application on hands and feet has a beneficial effect on peripheral neuropathy. Applying henna is a promising approach in CIPN management.en_US
dc.identifier.doi10.1016/j.ejon.2020.101827
dc.identifier.issn1462-3889
dc.identifier.issn1532-2122
dc.identifier.pmid32932009en_US
dc.identifier.scopus2-s2.0-85090696363en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1016/j.ejon.2020.101827
dc.identifier.urihttps://hdl.handle.net/20.500.12452/11833
dc.identifier.volume48en_US
dc.identifier.wosWOS:000580028400025en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.ispartofEuropean Journal Of Oncology Nursingen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChemotherapy-Induced Peripheral Neuropathyen_US
dc.subjectHennaen_US
dc.subjectNursingen_US
dc.subjectNon-Pharmacological Interventionen_US
dc.subjectComplementary Therapiesen_US
dc.titleThe preliminary effects of henna on chemotherapy-induced peripheral neuropathy in women receiving oxaliplatin-based treatment: A parallel-group, randomized, controlled pilot trialen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu